Clinical Trials Logo

Clinical Trial Summary

Open label randomized controlled clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in treating left ventricular thrombus in patients with acute or recent myocardial infarction (MI).

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05208398
Study type Interventional
Source Saud Al Babtain Cardiac Center
Status Completed
Phase Phase 3
Start date February 18, 2018
Completion date September 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05077683 - Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF Phase 3
Recruiting NCT04970576 - Rivaroxaban in Left Ventricular Thrombus Phase 4
Not yet recruiting NCT03415386 - Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus Phase 4
Completed NCT04871126 - Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI With Left Ventricular Dysfunction
Recruiting NCT03764241 - Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant Phase 3
Recruiting NCT04829825 - The "MyoThrombus" Study
Not yet recruiting NCT03786757 - Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ) Phase 3